z-logo
open-access-imgOpen Access
Detection of Lethal Dose 50 of Biofilm-producing Methicillin-resistant Staphylococcus aureus Local Isolate From Mastitis
Author(s) -
Abdullah Abdullazeez Sheehan,
Mohammed H. Khudor,
Fanar A. Isihak
Publication year - 2021
Publication title -
al-anbar journal of veterinary sciences
Language(s) - English
Resource type - Journals
eISSN - 2707-0603
pISSN - 1999-6527
DOI - 10.37940/ajvs.2021.14.2.3
Subject(s) - staphylococcus aureus , virulence , microbiology and biotechnology , mastitis , median lethal dose , pathogenicity , methicillin resistant staphylococcus aureus , medicine , staphylococcal infections , lethal dose , biology , veterinary medicine , bacteria , toxicology , toxicity , biochemistry , genetics , gene
It is very important, before starting the manufacture of any vaccine from any microorganism estimation of LD₅₀ of that microorganism to determine their pathogenicity and virulence. Estimated LD₅₀ was very important to be used in challenge tests later to estimate the protection level of the manufactured vaccine in experimental animals. So, this study was aimed to estimate LD₅₀ of local methicillin-resistant Staphylococcus aureus (MRSA) bacterial isolate. A pilot study has been done to determine approximately LD₅₀ of used MRSA in the study by using different bacterial concentrations of MRSA to determine approximate LD₅₀ that can be able to kill half numbers of animals used in the study to be used later in the estimation of exact LD₅₀ by using of Up-and-Down method. Ninety Wistar albino rats have been used for this purpose, eighty-four animals which divided into fourteen groups by six animals for each group (for pilot study) and remained six animals for (Up-and-Down method). The results showed that 9 X 10¹⁰ CFU/ml was led to killing half number of animals used in the study, this dose has been used as starting dose in the Up-and-Down method to the estimation of the exact LD₅₀ dose. The results showed that 5.526 X 10¹⁰ CFU/ml was the exact LD₅₀ of local MRSA isolate, which will be used later in the challenge test to estimate the protection level of a locally prepared vaccine against MRSA isolate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom